Global Stem Cell Banking Market 2018-2022
About Stem Cell Banking
The global stem cell banking market is a closely related market to the global regenerative medicine market. Regenerative medicine is a key branch of modern medicine, which has emerged as a combination of tissue engineering and molecular biology. Regenerative medicine aims to re-engineer human cells, tissues, or organs, which can replace or restore the normal functioning of impaired cells, tissues; or organs.
Technavio’s analysts forecast the global stem cell banking market to grow at a CAGR of 12.76% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global stem cell banking market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Stem Cell Banking Market 2018-2022
Technavio recognizes the following companies as the key players in the global stem cell banking market: AMAG Pharmaceuticals, Cordlife, Cryo-Cell International, and Esperite.
Other Prominent Vendors in the market are: Cellular Dynamics International, China Cord Blood Corporation, Cordvida, Cryo Stemcell, Cryoviva India, Cytori Therapeutics, Lifecell, PerkinElmer, Reelabs, Smart Cells International, Stemade Biotech, and StemCyte.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is growing acceptance of stem cell therapies. Growing concerns regarding organ transplants have increased the demand for stem cell therapy products. Conventional methods of organ transplantation are associated with the risk of infection, immunosuppression, and graft rejection. Some of the other complications include diabetes, high cholesterol, high blood pressure, and gastrointestinal problems.”
According to the report, one driver in the market is growing prevalence of cancer. Mutations in the genes and additions or deletions of genetic materials that regulate gene activity may lead to abnormal gene function, resulting in cancer. Furthermore, in cancer cells, gene expression is affected by alterations in the chemical mechanisms responsible for the production of gene proteins. If these changes alter expression of other genes, secondary effects on the overall gene expression can be observed, which gradually leads to the improper functioning of cellular components and signals, leading to malignancy.
AMAG Pharmaceuticals, Cordlife, Cryo-Cell International, Esperite, Cellular Dynamics International, China Cord Blood Corporation, Cordvida, Cryo Stemcell, Cryoviva India, Cytori Therapeutics, Lifecell, PerkinElmer, Reelabs, Smart Cells International, Stemade Biotech, and StemCyte.